Related Experiment Video
Updated: Mar 26, 2026

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.5K
White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutations
Donata Paternicò1, Enrico Premi2, Stefano Gazzina2
1Centre of Brain Aging, Neurology Unit, Department of Biomedical Sciences and Translational Medicine, University of Brescia, Brescia, Italy.
Neurobiology of Aging
|February 2, 2016
Summary
Frontotemporal dementia (FTD) patients with Granulin (GRN) gene mutations show increased white matter hyperintensities (WMHs). This finding may indicate a new neurodegeneration mechanism and aid in FTD diagnosis and genetic screening.
Area of Science:
- Neuroscience
- Genetics
- Neuropathology
Background:
- White matter hyperintensities (WMHs) are rarely reported in frontotemporal dementia (FTD).
- Previous studies identified WMHs in only 4 FTD cases with pathogenic Granulin (GRN) gene mutations.
Purpose of the Study:
- To investigate the presence and spatial distribution of WMHs in FTD patients with and without GRN mutations.
- To explore WMH burden in asymptomatic GRN mutation carriers.
Main Methods:
- Compared WMH burden and spatial distribution in FTD patients (GRN+ and GRN-), healthy controls (HC), and asymptomatic GRN+ subjects.
- Utilized automated WMH computation and voxelwise-based analysis.
Main Results:
- FTD-GRN+ patients exhibited significantly higher WMH burden than HC and FTD-GRN- groups.
- WMHs were predominantly located in the frontal, temporal, and parietal lobes.
- No significant WMH differences were found between asymptomatic GRN+ subjects and young healthy controls.
Conclusions:
- WMHs may represent a novel neurodegeneration mechanism in GRN-related FTD.
- Identifying WMHs could assist in the differential diagnosis of FTD.
- WMH findings may guide genetic screening for GRN mutations in FTD patients.
Related Concept Videos
Amyloid Fibrils
12.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.9K
Amyloid Fibrils
6.9K
6.9K

